title: [Objective DNA malignancy grading as adjunct to the histological Gleason score: Frankfurt consensus].
authors: Institut für Pathologie, Krankenhaus Düren, Roonstraße 30, 52309, Düren, Deutschland, alfred.boecking@web.de.
authors: A
authors: A
authors: Böcking
authors: S
authors: S
authors: Biesterfeld
authors: J
authors: J
authors: Dietz
authors: G
authors: G
authors: Haroske
authors: J
authors: J
authors: Kriegsmann
authors: H
authors: H
authors: Motherby
authors: S
authors: S
authors: Falk
mesh_terms: D001706:Biopsy; D020732:Cytogenetic Analysis; D004273:DNA, Neoplasm / Q000235:genetics*; D018450:Disease Progression; D005434:Flow Cytometry; D019983:Guideline Adherence; D006801:Humans; D007620:Karyometry; D008297:Male; D060787:Neoplasm Grading; D011003:Ploidies; D011379:Prognosis; D011467:Prostate / Q000473:pathology; D011471:Prostatic Neoplasms / Q000235:genetics* / Q000473:pathology* / Q000628:therapy; D057832:Watchful Waiting
chemical_list: D004273:DNA, Neoplasm